https://www.pharmacytimes.com/view/fda-approves-sibeprenlimab-for-patients-with-igan
FDA Approves Sibeprenlimab for Patients with IgAN | Pharmacy Times
Nov 26, 2025 - Sibeprenlimab offers a groundbreaking treatment for immunoglobulin A nephropathy, targeting APRIL to reduce kidney damage and improve patient outcomes.
fda approvespharmacy times
https://www.pharmacytimes.com/view/essential-oils-a-pharmacist-guide-for-alternative-pain-management
Essential Oils: A Pharmacist Guide for Alternative Pain Management | Pharmacy Times
Nov 24, 2025 - With Growing Patient Interest in Natural Remedies, Pharmacists Must Understand the Science, Safety, and Limitations of Essential Oils
pain management pharmacyoils
https://www.pharmacytimes.com/view/additional-clinical-considerations-with-cdk4-6-inhibitors
Additional Clinical Considerations With CDK4/6 Inhibitors | Pharmacy Times
Nov 20, 2025 - Panelists discuss broader clinical issues such as resistance, treatment duration, and quality of life in patients receiving CDK4/6 inhibitors.
additional clinicalinhibitors
https://hct.online/redcare-pharmacy-rueckkehr-zum-wachstum/
Redcare Pharmacy: Rückkehr zum Wachstum? | Health Care Times
May 6, 2025 - Trotz hoher Marketingausgaben bei Redcare Pharmacy: Die Kundenbasis wächst, weshalb man in den Niederlanden guter Dinge ist.
health care timeszum wachstum
Sponsored https://www.fanvue.com/mila_lerue
Mila LeRue - Fanvue
Come to play with me? Let me show you something you've never seen before babe...I'm waiting for you!
https://www.pharmacytimes.com/view/combination-of-olezarsen-and-fibrates-yields-enhanced-triglyceride-reduction
Combination of Olezarsen and Fibrates Yields Enhanced Triglyceride Reduction | Pharmacy Times
Nov 23, 2025 - Olezarsen effectively lowers triglycerides and enhances cardiovascular health, especially when combined with fibrates, benefiting pharmacists and patients...
combinationyieldsenhanced
https://www.pharmacytimesclinicalforum.com/event/pd-l1-inhibitors-in-nsclc-precision-personalization-and-practice-impact/
PD-L1 Inhibitors in NSCLC: Precision, Personalization, and Practice Impact | Pharmacy Times...
Advancing Heart Failure Management: Updates and Strategies for Iron Deficiency
nsclc precisionpdinhibitors
https://hct.online/e-rezept-beflugelt-umsatz-von-redcare-pharmacy/
E-Rezept beflügelt Umsatz von Redcare Pharmacy | Health Care Times
Jul 5, 2024 - Die vorläufigen Zahlen für das zweite Quartal des Jahres von Redcare Pharmacy zeigen: Vor allem das E-Rezept in Deutschland hat den niederländischen Konzern...
health care timesrezeptumsatz
https://www.pharmacytimesclinicalforum.com/
Pharmacy Times Clinical Forum Events Roundtable Discussions
Jun 25, 2024 - PHARMACY TIMES® CLINICAL FORUM Events are roundtable discussions led by specialized practitioners, offering insight on specific therapeutic areas.
pharmacy timesclinicalforum
https://www.pharmacytimes.com/shorts/pharmacists-are-key-to-cardiovascular-counseling-for-patients-with-narcolepsy
Pharmacists Are Key to Cardiovascular Counseling for Patients With Narcolepsy | Pharmacy Times
Richard Kovacs, MD, explains the critical role of pharmacists in counseling patients with narcolepsy for transitioning to low-sodium oxybate (Xywav; Jazz...
pharmacistskeycardiovascular